(Total Views: 77)
Posted On: 12/23/2019 12:00:42 PM
Post# of 47159

$TBPH News Article - Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inhibitor Program https://marketwirenews.com/news-releases/ther...78526.html


My Twitter: WhyteStocks